{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:43Z","timestamp":1792788343068,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000353"],"award-info":[{"award-number":["82000353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Key R&D Program of Sichuan Province","award":["2024YFFK0024"],"award-info":[{"award-number":["2024YFFK0024"]}]},{"name":"the Natural Science Foundation of Sichuan Province","award":["2023NSFSC1639"],"award-info":[{"award-number":["2023NSFSC1639"]}]},{"name":"the Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0521802"],"award-info":[{"award-number":["2024ZD0521802"]}]},{"name":"the Post Doctor Research Project, West China Hospital, Sichuan University","award":["20HXBH143"],"award-info":[{"award-number":["20HXBH143"]}],"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate pressure\u2013volume loop (PV-loop) changes by cardiovascular magnetic resonance (CMR) imaging in cardiac amyloidosis (CA) patients with preserved left ventricular ejection fraction (LVEF), and to assess PV-loop parameters\u2019 potential as subtype differential diagnostic markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Between May 2017 and September 2023, 100\u00a0consecutive confirmed CA patients (14 transthyretin-related [ATTR-CA] and 86 light-chain [AL-CA]) and 40 age- and sex-matched healthy controls (HCs) were prospectively enrolled. PV-loop parameters were derived from CMR cine images and brachial blood pressure. Clinical and CMR parameters were compared between CA patients and HCs, as well as between CA subtypes. The correlations between PV-loop parameters and clinical and imaging parameters were assessed. Furthermore, the differential diagnostic performance of these PV-loop parameters was evaluated using the area under the receiver operating characteristic curve (ROC-AUC). Bootstrapping was performed 2000 times for internal validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to HCs, CA patients showed significantly lower stroke work index, potential energy index (PEI), and work efficiency (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). AL-CA patients had higher N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (2358.00 [IQR: 903.25, 5559.00] vs 810.00 [IQR: 269.00, 1136.01] pg\/mL,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) and lower PEI (0.13 [IQR: 0.07, 0.15] vs 0.15 [IQR: 0.13, 0.19] J\/m\u00b2,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025) than ATTR-CA patients. NT-proBNP (\u03b2\u2009=\u2009\u22121.94, OR\u2009=\u20090.14, 95% CI: 0.03\u20130.64,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016) and PEI (\u03b2\u2009=\u20090.20, OR\u2009=\u20091.23, 95% CI: 1.07\u20131.44,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007) were independent predictors for AL-CA vs ATTR-CA differentiation, and combining these two parameters enhanced the diagnostic performance (bootstrapping AUC 0.847).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>By providing pathophysiological insights into the distinctions between AL-CA and ATTR-CA, PV-loop parameters have the potential to serve as a complementary, contrast-free approach for differential diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      PV-loop changes by CMR in CA patients with preserved LVEF remain unknown.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      Light-chain CA patients with preserved LVEF had higher NT-proBNP levels and lower PEI than transthyretin-related CA patients.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Critical relevance statement<\/jats:italic>\n                      <\/jats:bold>\n                      The CMR-derived PV-loop parameters revealed pathophysiological differences between the two subtypes of CA, suggesting potential differential diagnostic value.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02408-z","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:45:38Z","timestamp":1791560738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myocardial work in light-chain and transthyretin-related amyloidosis with preserved ejection fraction: a cardiovascular magnetic resonance study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9166-646X","authenticated-orcid":false,"given":"Shichu","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keying","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0601-8039","authenticated-orcid":false,"given":"Yucheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"2408_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00392-022-02114-y","volume":"112","author":"S Ney","year":"2023","unstructured":"Ney S, Ihle P, Ruhnke T et al (2023) Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018. Clin Res Cardiol 112:401\u2013408. https:\/\/doi.org\/10.1007\/s00392-022-02114-y","journal-title":"Clin Res Cardiol"},{"key":"2408_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2019.07.022","volume":"67","author":"AS Manolis","year":"2019","unstructured":"Manolis AS, Manolis AA, Manolis TA, Melita H (2019) Cardiac amyloidosis: an underdiagnosed\/underappreciated disease. Eur J Intern Med 67:1\u201313. https:\/\/doi.org\/10.1016\/j.ejim.2019.07.022","journal-title":"Eur J Intern Med"},{"key":"2408_CR3","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3324\/haematol.2013.094482","volume":"98","author":"G Merlini","year":"2013","unstructured":"Merlini G, Palladini G (2013) Light chain amyloidosis: the heart of the problem. Haematologica 98:1492\u20131495. https:\/\/doi.org\/10.3324\/haematol.2013.094482","journal-title":"Haematologica"},{"key":"2408_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg FL, Berk JL (2012) Transthyretin (TTR) cardiac amyloidosis. Circulation 126:1286\u20131300. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.078915","journal-title":"Circulation"},{"key":"2408_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/13506129.2022.2127088","volume":"30","author":"F Noborn","year":"2023","unstructured":"Noborn F, Thomsen C, Vorontsov E et al (2023) Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies. Amyloid 30:96\u2013108. https:\/\/doi.org\/10.1080\/13506129.2022.2127088","journal-title":"Amyloid"},{"key":"2408_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jcmg.2024.10.011","volume":"18","author":"M Fontana","year":"2025","unstructured":"Fontana M, Ioannou A, Cuddy S et al (2025) The last decade in cardiac amyloidosis: advances in understanding pathophysiology, diagnosis and quantification, prognosis, treatment strategies, and monitoring response. JACC Cardiovasc Imaging 18:478\u2013499. https:\/\/doi.org\/10.1016\/j.jcmg.2024.10.011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2408_CR7","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/ehjci\/jeaa063","volume":"21","author":"R Jurcu\u0163","year":"2020","unstructured":"Jurcu\u0163 R, Onciul S, Adam R et al (2020) Multimodality imaging in cardiac amyloidosis: a primer for cardiologists. Eur Heart J Cardiovasc Imaging 21:833\u2013844. https:\/\/doi.org\/10.1093\/ehjci\/jeaa063","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2408_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00392-020-01771-1","volume":"110","author":"G Chatzantonis","year":"2021","unstructured":"Chatzantonis G, Bietenbeck M, Elsanhoury A et al (2021) Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study. Clin Res Cardiol 110:555\u2013568. https:\/\/doi.org\/10.1007\/s00392-020-01771-1","journal-title":"Clin Res Cardiol"},{"key":"2408_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12968-021-00711-w","volume":"23","author":"H Steen","year":"2021","unstructured":"Steen H, Giusca S, Montenbruck M et al (2021) Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis. J Cardiovasc Magn Reson 23:45. https:\/\/doi.org\/10.1186\/s12968-021-00711-w","journal-title":"J Cardiovasc Magn Reson"},{"key":"2408_CR10","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10741-023-10332-3","volume":"28","author":"S Liang","year":"2023","unstructured":"Liang S, Liu Z, Li Q, He W, Huang H (2023) Advance of echocardiography in cardiac amyloidosis. Heart Fail Rev 28:1345\u20131356. https:\/\/doi.org\/10.1007\/s10741-023-10332-3","journal-title":"Heart Fail Rev"},{"key":"2408_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00392-023-02348-4","volume":"113","author":"H Steen","year":"2024","unstructured":"Steen H, Montenbruck M, Kallifatidis A et al (2024) Multi-parametric non-contrast cardiac magnetic resonance for the differentiation between cardiac amyloidosis and hypertrophic cardiomyopathy. Clin Res Cardiol 113:469\u2013480. https:\/\/doi.org\/10.1007\/s00392-023-02348-4","journal-title":"Clin Res Cardiol"},{"key":"2408_CR12","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1016\/j.jacc.2024.04.072","volume":"84","author":"S Liang","year":"2024","unstructured":"Liang S, Wan K, Li J, Chen J, Chen Y (2024) Patients with cardiac amyloidosis are more prone to hypotension. J Am Coll Cardiol 84:e233. https:\/\/doi.org\/10.1016\/j.jacc.2024.04.072","journal-title":"J Am Coll Cardiol"},{"key":"2408_CR13","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/eurheartj\/ehz552","volume":"41","author":"MB Bastos","year":"2020","unstructured":"Bastos MB, Burkhoff D, Maly J et al (2020) Invasive left ventricle pressure\u2013volume analysis: overview and practical clinical implications. Eur Heart J 41:1286\u20131297. https:\/\/doi.org\/10.1093\/eurheartj\/ehz552","journal-title":"Eur Heart J"},{"key":"2408_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/01.cir.81.2.703","volume":"81","author":"D Burkhoff","year":"1990","unstructured":"Burkhoff D (1990) The conductance method of left ventricular volume estimation. Methodologic limitations put into perspective. Circulation 81:703\u2013706. https:\/\/doi.org\/10.1161\/01.cir.81.2.703","journal-title":"Circulation"},{"key":"2408_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.118.008493","volume":"12","author":"F Seemann","year":"2019","unstructured":"Seemann F, Arvidsson P, Nordlund D et al (2019) Noninvasive quantification of pressure\u2013volume loops from brachial pressure and cardiovascular magnetic resonance. Circ Cardiovasc Imaging 12:e008493. https:\/\/doi.org\/10.1161\/CIRCIMAGING.118.008493","journal-title":"Circ Cardiovasc Imaging"},{"key":"2408_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/jcecho.jcecho_16_21","volume":"31","author":"G Palmiero","year":"2021","unstructured":"Palmiero G, Rubino M, Monda E et al (2021) Global left ventricular myocardial work efficiency in heart failure patients with cardiac amyloidosis: pathophysiological implications and role in differential diagnosis. J Cardiovasc Echogr 31:157\u2013164. https:\/\/doi.org\/10.4103\/jcecho.jcecho_16_21","journal-title":"J Cardiovasc Echogr"},{"key":"2408_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH et al (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004. Am J Hematol 79:319\u2013328. https:\/\/doi.org\/10.1002\/ajh.20381","journal-title":"Am J Hematol"},{"key":"2408_CR18","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y et al (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 42:1554\u20131568. https:\/\/doi.org\/10.1093\/eurheartj\/ehab072","journal-title":"Eur Heart J"},{"key":"2408_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","volume":"81","author":"Writing Committee","year":"2023","unstructured":"Writing Committee, Kittleson MM, Ruberg FL et al (2023) 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 81:1076\u20131126. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.022.","journal-title":"J Am Coll Cardiol"},{"key":"2408_CR20","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson MM, Panjrath GS, Amancherla K et al (2023) 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 81:1835\u20131878. https:\/\/doi.org\/10.1016\/j.jacc.2023.03.393","journal-title":"J Am Coll Cardiol"},{"key":"2408_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1148\/radiol.2018172435","volume":"288","author":"K Wan","year":"2018","unstructured":"Wan K, Sun J, Yang D et al (2018) Left ventricular myocardial deformation on cine MR images: relationship to severity of disease and prognosis in light-chain amyloidosis. Radiology 288:73\u201380. https:\/\/doi.org\/10.1148\/radiol.2018172435","journal-title":"Radiology"},{"key":"2408_CR22","unstructured":"The Criteria Committee of the New York Heart Association (1994) Nomenclature and criteria for diagnosis of diseases of the heart and great vessels, 9th revised edn. Little, Brown & Co., Boston, pp 253\u2013256"},{"key":"2408_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12968-023-00974-5","volume":"25","author":"Z Xu","year":"2023","unstructured":"Xu Z, Li W, Wang J et al (2023) Reference ranges of myocardial T1 and T2 mapping in healthy Chinese adults: a multicenter 3T cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 25:64. https:\/\/doi.org\/10.1186\/s12968-023-00974-5","journal-title":"J Cardiovasc Magn Reson"},{"key":"2408_CR24","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM et al (2024) 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 45:3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"key":"2408_CR25","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1161\/HYP.0000000000000249","volume":"82","author":"Writing Committee Members","year":"2025","unstructured":"Writing Committee Members, Jones DW, Ferdinand KC et al (2025) 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertension 82:e212\u2013e316. https:\/\/doi.org\/10.1161\/HYP.0000000000000249.","journal-title":"Hypertension"},{"key":"2408_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","volume":"22","author":"J Schulz-Menger","year":"2020","unstructured":"Schulz-Menger J, Bluemke DA, Bremerich J et al (2020) Standardized image interpretation and post-processing in cardiovascular magnetic resonance\u20142020 update: Society for Cardiovascular Magnetic Resonance (SCMR): board of trustees task force on standardized post-processing. J Cardiovasc Magn Reson 22:19. https:\/\/doi.org\/10.1186\/s12968-020-00610-6","journal-title":"J Cardiovasc Magn Reson"},{"key":"2408_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocmr.2026.102716","volume":"28","author":"S Liang","year":"2026","unstructured":"Liang S, Wan K, Deng Q et al (2026) Characteristics and clinical significance of myocardial work in cardiac light-chain amyloidosis: pressure\u2013volume loop analysis based on cardiovascular magnetic resonance. J Cardiovasc Magn Reson 28:102716. https:\/\/doi.org\/10.1016\/j.jocmr.2026.102716","journal-title":"J Cardiovasc Magn Reson"},{"key":"2408_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32\u201335. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3","journal-title":"Cancer"},{"key":"2408_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jacasi.2025.03.002","volume":"5","author":"S Liang","year":"2025","unstructured":"Liang S, Huang H, Chen Y (2025) Echocardiography in cardiac amyloidosis: from identification to classification. JACC Asia 5:647\u2013649. https:\/\/doi.org\/10.1016\/j.jacasi.2025.03.002","journal-title":"JACC Asia"},{"key":"2408_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1186\/s12872-025-04973-5","volume":"25","author":"S Liang","year":"2025","unstructured":"Liang S, Liu Z, Shi F et al (2025) Development and validation of an echocardiographic nomogram for identifying cardiac amyloidosis in patients with left ventricular hypertrophy. BMC Cardiovasc Disord 25:767. https:\/\/doi.org\/10.1186\/s12872-025-04973-5","journal-title":"BMC Cardiovasc Disord"},{"key":"2408_CR31","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/ehjci\/jeae095","volume":"25","author":"B Slostad","year":"2024","unstructured":"Slostad B, Appadurai V, Narang A et al (2024) Novel echocardiographic pixel intensity quantification method for differentiating transthyretin cardiac amyloidosis from light chain cardiac amyloidosis and other phenocopies. Eur Heart J Cardiovasc Imaging 25:1601\u20131611. https:\/\/doi.org\/10.1093\/ehjci\/jeae095","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2408_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133164","volume":"429","author":"T Sugimoto","year":"2025","unstructured":"Sugimoto T, Kayama K, Kawada Y et al (2025) Relative interventricular septal brightness for subtype diagnosis of cardiac amyloidosis: results from the JSE J-CASE study. Int J Cardiol 429:133164. https:\/\/doi.org\/10.1016\/j.ijcard.2025.133164","journal-title":"Int J Cardiol"},{"key":"2408_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","volume":"7","author":"JN Dungu","year":"2014","unstructured":"Dungu JN, Valencia O, Pinney JH et al (2014) CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging 7:133\u2013142. https:\/\/doi.org\/10.1016\/j.jcmg.2013.08.015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2408_CR34","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","volume":"132","author":"M Fontana","year":"2015","unstructured":"Fontana M, Pica S, Reant P et al (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 132:1570\u20131579. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016567","journal-title":"Circulation"},{"key":"2408_CR35","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jchf.2024.07.003","volume":"12","author":"JD Schilling","year":"2024","unstructured":"Schilling JD, Nuvolone M, Merlini G (2024) The pathophysiological and therapeutic implications of cardiac light-chain amyloidosis compared with transthyretin amyloidosis. JACC Heart Fail 12:1781\u20131787. https:\/\/doi.org\/10.1016\/j.jchf.2024.07.003","journal-title":"JACC Heart Fail"},{"key":"2408_CR36","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1002\/ehf2.14852","volume":"11","author":"G Neculae","year":"2024","unstructured":"Neculae G, Adam R, Jercan A et al (2024) Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms. ESC Heart Fail 11:2825\u20132834. https:\/\/doi.org\/10.1002\/ehf2.14852","journal-title":"ESC Heart Fail"},{"key":"2408_CR37","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","volume":"120","author":"C Rapezzi","year":"2009","unstructured":"Rapezzi C, Merlini G, Quarta CC et al (2009) Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120:1203\u20131212. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.843334","journal-title":"Circulation"},{"key":"2408_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2796.2007.01888.x","volume":"263","author":"OB Suhr","year":"2008","unstructured":"Suhr OB, Anan I, Backman C et al (2008) Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis? J Intern Med 263:294\u2013301. https:\/\/doi.org\/10.1111\/j.1365-2796.2007.01888.x","journal-title":"J Intern Med"},{"key":"2408_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","volume":"13","author":"A Baggiano","year":"2020","unstructured":"Baggiano A, Boldrini M, Martinez-Naharro A et al (2020) Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 13:69\u201380. https:\/\/doi.org\/10.1016\/j.jcmg.2019.03.026","journal-title":"JACC Cardiovasc Imaging"},{"key":"2408_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1148\/radiol.2015141744","volume":"277","author":"M Fontana","year":"2015","unstructured":"Fontana M, Banypersad SM, Treibel TA et al (2015) Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study. Radiology 277:388\u2013397. https:\/\/doi.org\/10.1148\/radiol.2015141744","journal-title":"Radiology"},{"key":"2408_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12968-018-0478-3","volume":"20","author":"F Ridouani","year":"2018","unstructured":"Ridouani F, Damy T, Tacher V et al (2018) Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis. J Cardiovasc Magn Reson 20:58. https:\/\/doi.org\/10.1186\/s12968-018-0478-3","journal-title":"J Cardiovasc Magn Reson"},{"key":"2408_CR42","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/ehjci\/jeae154","volume":"25","author":"D Kravchenko","year":"2024","unstructured":"Kravchenko D, Isaak A, Zimmer S et al (2024) Parametric mapping using cardiovascular magnetic resonance for the differentiation of light chain amyloidosis and transthyretin-related amyloidosis. Eur Heart J Cardiovasc Imaging 25:1451\u20131461. https:\/\/doi.org\/10.1093\/ehjci\/jeae154","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2408_CR43","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jcmg.2015.11.001","volume":"8","author":"P Claus","year":"2015","unstructured":"Claus P, Omar AMS, Pedrizzetti G, Sengupta PP, Nagel E (2015) Tissue tracking technology for assessing cardiac mechanics: principles, normal values, and clinical applications. JACC Cardiovasc Imaging 8:1444\u20131460. https:\/\/doi.org\/10.1016\/j.jcmg.2015.11.001","journal-title":"JACC Cardiovasc Imaging"},{"key":"2408_CR44","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.echo.2023.08.005","volume":"36","author":"JA Slivnick","year":"2023","unstructured":"Slivnick JA, Singulane C, Sun D et al (2023) Preservation of circumferential and radial left ventricular function as a mitigating mechanism for impaired longitudinal strain in early cardiac amyloidosis. J Am Soc Echocardiogr 36:1290\u20131301. https:\/\/doi.org\/10.1016\/j.echo.2023.08.005","journal-title":"J Am Soc Echocardiogr"},{"key":"2408_CR45","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1111\/bjh.70122","volume":"207","author":"F Meng","year":"2025","unstructured":"Meng F, Li J, Zhao R et al (2025) Myocardial work indices in the short-term prognosis of light-chain cardiac amyloidosis: incremental value beyond traditional staging models and echocardiographic parameters. Br J Haematol 207:1962\u20131972. https:\/\/doi.org\/10.1111\/bjh.70122","journal-title":"Br J Haematol"},{"key":"2408_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.echo.2019.11.018","volume":"33","author":"TS Clemmensen","year":"2020","unstructured":"Clemmensen TS, Eiskj\u00e6r H, Mikkelsen F et al (2020) Left ventricular pressure-strain-derived myocardial work at rest and during exercise in patients with cardiac amyloidosis. J Am Soc Echocardiogr 33:573\u2013582. https:\/\/doi.org\/10.1016\/j.echo.2019.11.018","journal-title":"J Am Soc Echocardiogr"},{"key":"2408_CR47","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/eurjpc\/zwae093","volume":"31","author":"A Aimo","year":"2024","unstructured":"Aimo A, Vergaro G, Castiglione V et al (2024) Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study. Eur J Prev Cardiol 31:1410\u20131417. https:\/\/doi.org\/10.1093\/eurjpc\/zwae093","journal-title":"Eur J Prev Cardiol"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02408-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02408-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02408-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:45:40Z","timestamp":1791560740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02408-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2408"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02408-z","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures involving human participants performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and the 1964 Helsinki Declaration. This prospective study was approved by the Institutional Review Board of West China Hospital, Sichuan University, and was registered with the Chinese Clinical Trial Registry (ChiCTR1900024764). Written informed consent for participation in the study was obtained from each patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors report that they have no relationships relevant to the content of this paper.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"245"}}